The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris
- 1 December 2000
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 43 (6) , 1058-1064
- https://doi.org/10.1067/mjd.2000.109297
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Influence of treatment on the clinical course of pemphigus vulgarisJournal of the American Academy of Dermatology, 1996
- The Extracellular Aminoterminal Domain of Bovine Desmoglein 1 (Dsg1) Is Recognized Only by Certain Pemphigus Foliaceus Sera, Whereas Its Intracellular Domain Is Recognized by Both Pemphigus Vulgaris and Pemphigus Foliaceus SeraJournal of Investigative Dermatology, 1994
- Pemphigus in remission: Value of negative direct immunofluorescence in managementJournal of the American Academy of Dermatology, 1994
- Treatment of PemphigusInternational Journal of Dermatology, 1991
- Detection of Cross-Reactive Idiotypes in the Serum of Patients with Bullous PemphigoidJournal of Investigative Dermatology, 1990
- Cyclophosphamide (Cytoxan)Journal of the American Academy of Dermatology, 1984
- Death in pemphigusJournal of the American Academy of Dermatology, 1982
- Plasma exchange in the treatment of pemphigus vulgarisBritish Journal of Dermatology, 1978
- An organ culture model for the study of pemphigus acantholysisBritish Journal of Dermatology, 1977
- Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis.BMJ, 1975